PD-L1 blockade efficacy relies on host cell PD-L1

被引：0
|
作者：
Brownell, I.
Udey, M.
机构：
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2018年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1000 / 1000
页数：1
相关论文
共 50 条
  • [21] PD-1 and PD-L1 blockade in gastrointestinal malignancies
    Lote, Hazel
    Cafferkey, Catherine
    Chau, Ian
    CANCER TREATMENT REVIEWS, 2015, 41 (10) : 893 - 903
  • [22] Mechanisms of Resistance to PD-1 and PD-L1 Blockade
    Nowicki, Theodore S.
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    CANCER JOURNAL, 2018, 24 (01): : 47 - 53
  • [23] Lactic acid inhibits the interaction between PD-L1 protein and PD-L1 antibody in the PD-1/PD-L1 blockade therapy-resistant tumor
    Oh, Wonkyung
    Kim, Alyssa Min Jung
    Dhawan, Deepika
    Knapp, Deborah W.
    Lim, Seung-Oe
    MOLECULAR THERAPY, 2025, 33 (02)
  • [24] Mild hyperthermia upregulates PD-L1 in the tumor microenvironment and enhances antitumor efficacy of PD-L1 blockade in murine squamous cell carcinoma
    Ohta, Yuya
    Ichimura, Norihisa
    Yamaguchi, Satoshi
    Ohara, Go
    Yamamoto, Noriyuki
    Itoh, Yoshiyuki
    Yamada, Keiichiro
    Nakamura, Seiji
    Hibi, Hideharu
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2024, 86 (03): : 497 - 506
  • [25] PD-L1 blockade for urothelial carcinoma
    Kang, Josephine
    Galluzzi, Lorenzo
    ONCOIMMUNOLOGY, 2017, 6 (07):
  • [26] From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
    Zhao, Xuan
    Bao, Yulin
    Meng, Bi
    Xu, Zijian
    Li, Sijin
    Wang, Xu
    Hou, Rui
    Ma, Wen
    Liu, Dan
    Zheng, Junnian
    Shi, Ming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells
    Tu, Jingyao
    Xu, Haoran
    Ma, Li
    Li, Chunya
    Qin, Wan
    Chen, Xinyi
    Yi, Ming
    Sun, Li
    Liu, Bo
    Yuan, Xianglin
    THERANOSTICS, 2022, 12 (02): : 747 - 766
  • [28] PD-L1
    Kythreotou, Anthousa
    Siddique, Abdul
    Mauri, Francesco A.
    Bower, Mark
    Pinato, David J.
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (03) : 189 - 194
  • [29] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
    Duruisseaux, Michael
    Rouquette, Isabelle
    Adam, Julien
    Cortot, Alexis
    Cazes, Aurelie
    Gibault, Laure
    Damotte, Diane
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
  • [30] Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
    Fei Tang
    Pan Zheng
    Cell & Bioscience, 8
12345